Improving Access and Multiple Sclerosis Care in Latin America

Improving Access and Multiple Sclerosis Care in Latin America

Faculty & Disclosures

RiveraModerator

Victor M. Rivera, MD, FAAN
Distinguished Emeritus Professor of Neurology
Founding Director of the Maxine Mesinger MS Clinic
Baylor College of Medicine
Houston, TX

Dr. Victor M. Rivera, Distinguished Emeritus Professor of Neurology at Baylor College of Medicine, Adjunct Professor of Research at the University of Houston, Senior member and Fellow of the American Academy of Neurology, Founder of the Mexican Academy of Neurology and the Latin American Committee for Treatment and Research in MS (LACTRIMS) serving as its President for 2 consecutive terms. He is also Founder and First Director of the Maxine Mesinger Multiple Sclerosis Comprehensive Care Center & Clinic of Baylor College of Medicine at The Methodist Hospital (TMH) in Houston, Texas.

Faculty

CorrealeJorge Correale, MD
Head of Neuroimmunology, Fleni, Buenos Aires
Vice-Chair, of the International Medical and Scientific Board MSIF
Member of the International Committee for Clinical Trials in MS
Buenos Aires, Argentina

Dr. Jorge Correale graduated with honors from the Faculty of Medicine, University of Buenos Aires, in 1981. Between 1983 and 1988 he completed the residency of Neurology at the Dr. José María Ramos Mejía Hospital, Buenos Aires, and was appointed Chief of Residents.  During the year 1989 he collaborated in the Department of Neuropathology, in the same center. Dr. Correale continued his training as a fellow in Neuroimmunology at the Karolinska Institute in Stockholm, Sweden, between 1989 and 1990. In 1990 he moved to the United States, where he completed a second three-year fellowship in Neuroimmunology at the University of Southern California, with support of the National Multiple Sclerosis Society USA. In 1993 he was appointed Assistant Professor of Neurology at the University of Southern California, and in 1995 Assistant Professor of Microbiology and Molecular Immunology. In 1997, Dr. Correale returned to Buenos Aires as Head of Neuroimmunology and Demyelinating Diseases at the Neurological Research Institute Dr. Raúl Carrea, a position he currently holds, where he develops an intense assistance task in the evaluation and follow-up of MS patients. Between 1998 and 2010 he was Associate Professor at the Austral University in Buenos Aires, teaching Clinical Neurophysiology, Physiopathology and Pain Treatment, and Neurology.

The main objective of Dr. Correale's work is to elucidate the role of environmental factors that determine the development or progression of Multiple Sclerosis, understanding the immunological mechanisms implicated. Additionally, the working group of Dr. Correale is focused on evaluating the clinical and immunological variations that are unleashed in particular circumstances of patients with multiple sclerosis such as assisted fertilization, pregnancy and puerperium, as well as the role that sex hormones play in each of these situations. Since 2013 Dr. Correale is working at the School of Pharmacy and Biochemistry of the University of Buenos Aires in the biology of glial cells, with the aim of developing models that allow a better understanding of the processes involved in demyelination and remyelination. Dr Correale is a member of the editorial board of different journals of Neurology and Immunology, and he participates in the scientific review panels of the Multiple Sclerosis Societies of Italy, the United Kingdom, Ireland, the Netherlands, Australia, and France, collaborating nationally in the evaluation of scientific projects of the Agency for Scientific and Technological Promotion and the Secretary of Science and Technology of the University of Buenos Aires. 

Currently, Dr. Correale is a member of the Argentine Medical Advisory Council for Multiple Sclerosis, and a member of the Medical and Scientific Board of the MSIF.  He has been former  Vice President and President of the Argentine Neurological Society, between 2008-2012, President of the Latin American Society for the Study and Treatment of Multiple Sclerosis (LACTRIMS) during the period 2014-2016, and member of the Advisory Board of the International Society of Neuroimmunology (ISNI). He is currently Deputy Chair of the MSIF and, and member of the International Advisory Committee on Clinical Trials in MS. Dr. Correale is author of 190 articles published in prestigious journals of Neurology and Immunology, 250 abstracts presented at different international forums in Europe, USA and Canada, 47 chapters in books on Neurology, Multiple Sclerosis, and Neuroimmunology, and published as an editor or co-editor 7 books related to Neurology, Multiple Sclerosis, and Neuroimmunology.   

Lana-PeixotoMarco Lana-Peixoto, MD
Full Professor of Neurology and Ophthalmology
Federal University of Minas Gerais Medical School
Belo Horizonte, Brazil

Marco A. Lana-Peixoto, MD, MSc (R), PhD, is Professor of Neurology and Ophthalmology at the Federal University of Minas Gerais Medical School in Belo Horizonte, Brazil. He is a Founder of the Brazilian Committee for Treatment and Research in Multiple Sclerosis (BCTRIMS) and served as its first President. He is also a Founding Member and former President of the Latin American Committee for Treatment and Research in Multiple Sclerosis (LACTRIMS). Presently, he serves as Chairman of BCTRIMS Steering Committee and Director of CIEM Multiple Sclerosis Investigation Center at the University of Minas Gerais Medical School where he is active in medical education and conduction of clinical research with focus in multiple sclerosis, neuromyelitis optica and optic neuritis. He has authored or co-authored a huge number of papers in peer-reviewed journals and book chapters in the field of demyelinating diseases and neuro-ophthalmology.

BeckerJefferson Becker, MD
Professor of Neurology 
Pontifical Catholic University of Rio Grande do Sul Medical School
President of the Brazilian Committee for Treatment and Research in Multiple Sclerosis (BCTRIMS)
Porto Alegre, Brazil

Jefferson  Becker graduated in  Medicine from the Federal University of Rio Grande do Sul  (UFRGS)  in  1994  and completed a specialism in  Neurology at the  São  Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul (PUCRS), from 1995 to 1997, in  Porto  Alegre,  Brazil.  He subsequently undertook a Fellowship in Neurology at the National  Hospital for  Neurology and Neurosurgery, in London, UK, between 1998 and  1999,  before completing an  MSc and PhD in  Neurosciences at  PUCRS,  in  2002 and  2005,  respectively.  He is currently an Assistant  Professor of  Neurology and Internal Medicine at PUCRS. Prof. Becker is the current  President of the  Brazilian Committee for  Treatment and  Research in Multiple  Sclerosis  (BCTRIMS)  and is a member of the  Scientific  Committee in Neuroimmunology of the Brazilian Academy of  Neurology.  His main research interests focus are on  Demyelinating  Diseases and Neuromuscular Disorders.

Name of Faculty/ Reported Financial Relationship

Dr. Victor Rivera, Dr. Marco Lana-Peixoto and Dr. Jefferson Becker disclose no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months.

Dr. Jorge Correale has served as a Consultant for Novartis, Merck and Biogen in Argentina. He has served as a Speaker for Novartis, Merck, Roche and Biogen in Argentina.

Other Contributor/Planner Disclosures

Dr. Melvin CW Wong, MD served as a peer reviewer for this activity as served as a Consultant for Portola Pharmaceuticals, Inc.

Additional non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

Learner Assurance Statement
Horizon CME requires instructors, planners, managers and other individuals who are in a position to influence the content of this activity to disclose any real or apparent conflict of interest (COI) which may arise as a result of prospective faculty members' relevant relationships with drug or device manufacturer(s). Horizon CME is committed to resolving all conflicts of interest and retaining only those speakers with financial interest conflicts that can be reconciled with the goals and educational integrity of the CME activity.

FREE